Holen Sie sich die Stockscreener-App
4.98
1.84%
0.09
Handel nachbörslich:
4.96
-0.02
-0.40%
Schlusskurs vom Vortag:
$4.89
Offen:
$4.75
24-Stunden-Volumen:
567.54K
Relative Volume:
0.74
Marktkapitalisierung:
$276.23M
Einnahmen:
$163.78M
Nettoeinkommen (Verlust:
$25.88M
KGV:
7.6615
EPS:
0.65
Netto-Cashflow:
$-28.66M
1W Leistung:
+5.29%
1M Leistung:
+19.14%
6M Leistung:
+56.11%
1J Leistung:
-32.34%
1-Tages-Spanne:
$4.72
$5.05
1-Wochen-Bereich:
$4.6701
$5.55
52-Wochen-Spanne:
$2.645
$8.275
Voyager Therapeutics Inc Stock (VYGR) Company Profile
Firmenname
Voyager Therapeutics Inc
Sektor
Branche
Telefon
857-259-5340
Adresse
75 HAYDEN AVENUE, LEXINGTON, MA
Vergleichen Sie VYGR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
4.98 | 271.24M | 163.78M | 25.88M | -28.66M | 0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-02 | Eingeleitet | Citigroup | Buy |
| 2024-11-29 | Fortgesetzt | Wedbush | Outperform |
| 2024-10-16 | Eingeleitet | Leerink Partners | Outperform |
| 2024-03-26 | Eingeleitet | Guggenheim | Buy |
| 2024-03-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-07 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | Eingeleitet | Truist | Buy |
| 2023-03-10 | Eingeleitet | Oppenheimer | Outperform |
| 2021-10-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-02-03 | Herabstufung | Wedbush | Outperform → Neutral |
| 2020-12-24 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-11-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-15 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | Fortgesetzt | BTIG Research | Buy |
| 2018-09-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-12 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-03-12 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-02-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-11-28 | Fortgesetzt | Piper Jaffray | Overweight |
| 2017-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-10-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-23 | Bestätigt | Stifel | Buy |
| 2017-10-12 | Eingeleitet | Raymond James | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-28 | Fortgesetzt | Stifel | Buy |
Alle ansehen
Voyager Therapeutics Inc Aktie (VYGR) Neueste Nachrichten
Using portfolio simulators with Voyager Therapeutics Inc. includedWeekly Loss Report & Safe Capital Growth Tips - newser.com
Is Voyager Therapeutics Inc. stock affected by interest rate hikesMarket Performance Recap & Real-Time Volume Trigger Notifications - newser.com
Price action breakdown for Voyager Therapeutics Inc.Earnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Applying Elliott Wave Theory to Voyager Therapeutics Inc.Market Trend Review & Community Verified Watchlist Alerts - newser.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Is Voyager Therapeutics Inc a good long term investmentLow Risk Investment Ideas & High Return Portfolio Growth - earlytimes.in
What drives Voyager Therapeutics Inc stock priceEarnings Volatility Patterns & AI Alerts You Can Actually Trust - earlytimes.in
Exit strategy if you’re trapped in Voyager Therapeutics Inc.Quarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
How moving averages guide Voyager Therapeutics Inc. trading2025 Short Interest & Stock Market Timing Techniques - newser.com
Voyager Therapeutics (NASDAQ:VYGR) Earns Sell (D) Rating from Weiss Ratings - MarketBeat
Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Voyager Therapeutics (NASDAQ:VYGR) CFO Nathan Jorgensen Sells 7,666 Shares - MarketBeat
Why Momentum Traders Are Watching Glenmark Pharmaceuticals Limited Stock CloselyCandlestick Trading Patterns & Next-Level Stock Intelligence, Now Free - earlytimes.in
Oppenheimer Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛
Does Voyager Therapeutics Inc. show high probability of reboundQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Voyager Therapeutics Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & Superior Capital Appreciation - earlytimes.in
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Held Back By Insufficient Growth Even After Shares Climb 27% - simplywall.st
Strs Ohio Makes New Investment in Voyager Therapeutics, Inc. $VYGR - MarketBeat
Goldman Sachs Group Inc. Sells 67,877 Shares of Voyager Therapeutics, Inc. $VYGR - Defense World
Can Voyager Therapeutics Inc. hit a new high this monthJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
What recovery options are there for Voyager Therapeutics Inc.2025 Volatility Report & Low Drawdown Momentum Trade Ideas - newser.com
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Exit Recap: Is Voyager Therapeutics Inc stock a smart retirement pickJuly 2025 Analyst Calls & Safe Entry Point Identification - khodrobank.com
Pullback Watch: How does Voyager Therapeutics Inc compare to its peersPortfolio Risk Report & Verified High Yield Trade Plans - khodrobank.com
Aug Retail: Is DigiAsia Corp. currently under institutional pressureJuly 2025 Update & Reliable Entry Point Trade Alerts - khodrobank.com
Is Voyager Therapeutics Inc. trending in predictive chart modelsWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Voyager Therapeutics (NASDAQ:VYGR) Earns "Buy" Rating from HC Wainwright - MarketBeat
Market Fear: Can Voyager Therapeutics Inc continue delivering strong returnsMarket Sentiment Report & Technical Entry and Exit Alerts - khodrobank.com
Trading Recap: Can Voyager Therapeutics Inc continue delivering strong returnsAnalyst Downgrade & Growth Oriented Trade Recommendations - خودرو بانک
Inflation Data: Is Voyager Therapeutics Inc a stock for growth or value investorsCEO Change & AI Optimized Trading Strategy Guides - خودرو بانک
Buyout Rumor: Is Voyager Therapeutics Inc. subject to activist investor interest2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Combining price and volume data for Voyager Therapeutics Inc.Price Action & Safe Investment Capital Preservation Plans - newser.com
Will Voyager Therapeutics Inc. continue its uptrend2025 Pullback Review & Reliable Price Breakout Alerts - newser.com
Aug Setups: How does FUFU correlate with NasdaqMarket Trend Report & Weekly Chart Analysis and Guides - خودرو بانک
Aug Spikes: Can Voyager Therapeutics Inc reach all time highs this year2025 Bull vs Bear & Free Community Consensus Stock Picks - خودرو بانک
Take Profit: Is Voyager Therapeutics Inc.’s growth already priced inEarnings Performance Report & Smart Swing Trading Alerts - خودرو بانک
When is the best time to exit Voyager Therapeutics Inc.Earnings Summary Report & Free Community Consensus Stock Picks - newser.com
Finanzdaten der Voyager Therapeutics Inc-Aktie (VYGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):